Genetics in MedicineGenetic & Genomic MedicinePeer-reviewed journal article
Centers for Mendelian Genomics: A decade of facilitating gene discovery
Samantha M. BaxteriD, Jennifer Ellen PoseyiD, Nicole J. LakeiD, Nara Lygia de Macena SobreiraiD, Jessica X. ChongiD, Steven G. BuyskeiD, Elizabeth BlueiD, Lisa Helbling ChadwickiD, Zeynep Coban‐AkdemiriD, Kimberly Floy DohenyiD, Colleen P. Davis, Monkol LekiD, Christopher Wellington, Shalini N. JhangianiiD, Mark GersteiniD, Richard A. GibbsiD, Richard P. LiftoniD, Daniel G. MacArthuriD, Tara Cox MatiseiD, James R. LupskiiD, David L. ValleiD, Michael J. BamshadiD, Ada HamoshiD, Shrikant ManeiD, Deborah A. NickersoniD, , Kurt N. HetrickiD
Abstract
Mendelian disease genomic research has undergone a massive transformation over the last decade. With increasing availability of exome and genome sequencing, the role of Mendelian research has expanded beyond data collection, sequencing, and analysis to worldwide data sharing and collaboration. Over the last 10 years, the NIH-supported Centers for Mendelian Genomics (CMGs) have played a major role in this research and clinical evolution. We highlight the cumulative gene discoveries facilitated by the program, biomedical research leveraged by the approach, and the larger impact on the research community. Mendelian genomic research extends beyond generating lists of gene-phenotype relationships, it includes developing tools, training the larger community to use these tools and approaches, and facilitating collaboration through data sharing. Thus, the CMGs have also focused on creating resources, tools, and training for the larger community to foster the understanding of genes and genome variation. The CMGs have participated in a wide range of data sharing activities, including deposition of all eligible CMG data into AnVIL (NHGRIs Genomic Data Science Analysis, Visualization, and Informatics Lab-Space), sharing candidate genes through Matchmaker Exchange (MME) and the CMG website, and sharing variants in Geno2MP and VariantMatcher. The research genomics output remains exploratory with evidence that thousands of disease genes, in which variant alleles contribute to disease, remain undiscovered, and many patients with rare disease remain molecularly undiagnosed. Strengthening communication between research and clinical labs, continued development and sharing of knowledge and tools required for solving previously unsolved cases, and improving access to data sets, including high-quality metadata, are all required to continue to advance Mendelian genomics research and continue to leverage the Human Genome Project for basic biomedical science research and clinical utility.
- organism: human
- assay: whole-exome sequencing
- assay: whole-genome sequencing
- research focus: database / resource
- research focus: gene regulatory network inference
- research focus: variant calling
- research focus: variant effect prediction
- approach: benchmark study
- Citations
- 72
- FWCI
- 2.54
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Considerations for reporting variants in novel candidate genes identified during clinical genomic testing
Jessica X. Chong, Seth Berger, … Tanner D. Jensen·Genetics in MedicinePeer-reviewed·Jun 26, 2024
- Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features
Jessica Chong, Joon-Ho Yu, … Michael J Bamshad·bioRxiv·Oct 3, 2015
- MendelVar: gene prioritization at GWAS loci using phenotypic enrichment of Mendelian disease genes
Maria Sobczyk, Tom R. Gaunt, Lavinia Paternoster·BioinformaticsPeer-reviewed·Jan 1, 2021
- GA4GH Phenopacket-Driven Characterization of Genotype-Phenotype Correlations in Mendelian Disorders
Lauren Rekerle, Daniel Danis, … Peter N. Robinson·The American Journal of Human GeneticsPeer-reviewed·Dec 23, 2025
- Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset
Ben Heavner, Marsha M. Wheeler, … Jessica X. Chong·bioRxiv·May 19, 2026
- The GA4GH Phenopacket schema: A computable representation of clinical data for precision medicine
Julius O.B. Jacobsen, Michael Baudis, … Peter N. Robinson·Nature BiotechnologyPeer-reviewed·Jun 1, 2022